EMEA (Europe, Middle East and Africa) Thalidomide Market Report 2017

December 2017 | 104 pages | ID: E8C7AA30F7FEN
QYResearch

Abstracts

In this report, the EMEA Thalidomide market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Thalidomide for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Thalidomide market competition by top manufacturers/players, with Thalidomide sales volume (K MT), price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Celgene

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Purity:98%
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Leprosy
• Arthropathy

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Thalidomide Market Report 2017

1 THALIDOMIDE OVERVIEW

1.1 Product Overview and Scope of Thalidomide
1.2 Classification of Thalidomide
  1.2.1 EMEA Thalidomide Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Thalidomide Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Purity:98%
  1.2.4 Others
1.3 EMEA Thalidomide Market by Application/End Users
  1.3.1 EMEA Thalidomide Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Leprosy
  1.3.3 Arthropathy
1.4 EMEA Thalidomide Market by Region
  1.4.1 EMEA Thalidomide Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Thalidomide (2012-2022)
  1.5.1 EMEA Thalidomide Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Thalidomide Revenue and Growth Rate (2012-2022)

2 EMEA THALIDOMIDE COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Thalidomide Market Competition by Players/Manufacturers
  2.1.1 EMEA Thalidomide Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Thalidomide Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Thalidomide Sale Price by Players (2012-2017)
2.2 EMEA Thalidomide (Volume and Value) by Type/Product Category
  2.2.1 EMEA Thalidomide Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Thalidomide Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Thalidomide Sale Price by Type (2012-2017)
2.3 EMEA Thalidomide (Volume) by Application
2.4 EMEA Thalidomide (Volume and Value) by Region
  2.4.1 EMEA Thalidomide Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Thalidomide Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Thalidomide Sales Price by Region (2012-2017)

3 EUROPE THALIDOMIDE (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Thalidomide Sales and Value (2012-2017)
  3.1.1 Europe Thalidomide Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Thalidomide Revenue and Growth Rate (2012-2017)
3.2 Europe Thalidomide Sales and Market Share by Type
3.3 Europe Thalidomide Sales and Market Share by Application
3.4 Europe Thalidomide Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Thalidomide Sales Volume by Countries (2012-2017)
  3.4.2 Europe Thalidomide Revenue by Countries (2012-2017)
  3.4.3 Germany Thalidomide Sales and Growth Rate (2012-2017)
  3.4.4 France Thalidomide Sales and Growth Rate (2012-2017)
  3.4.5 UK Thalidomide Sales and Growth Rate (2012-2017)
  3.4.6 Russia Thalidomide Sales and Growth Rate (2012-2017)
  3.4.7 Italy Thalidomide Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Thalidomide Sales and Growth Rate (2012-2017)

4 MIDDLE EAST THALIDOMIDE (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Thalidomide Sales and Value (2012-2017)
  4.1.1 Middle East Thalidomide Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Thalidomide Revenue and Growth Rate (2012-2017)
4.2 Middle East Thalidomide Sales and Market Share by Type
4.3 Middle East Thalidomide Sales and Market Share by Application
4.4 Middle East Thalidomide Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Thalidomide Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Thalidomide Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Thalidomide Sales and Growth Rate (2012-2017)
  4.4.4 Israel Thalidomide Sales and Growth Rate (2012-2017)
  4.4.5 UAE Thalidomide Sales and Growth Rate (2012-2017)
  4.4.6 Iran Thalidomide Sales and Growth Rate (2012-2017)

5 AFRICA THALIDOMIDE (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Thalidomide Sales and Value (2012-2017)
  5.1.1 Africa Thalidomide Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Thalidomide Revenue and Growth Rate (2012-2017)
5.2 Africa Thalidomide Sales and Market Share by Type
5.3 Africa Thalidomide Sales and Market Share by Application
5.4 Africa Thalidomide Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Thalidomide Sales Volume by Countries (2012-2017)
  5.4.2 Africa Thalidomide Revenue by Countries (2012-2017)
  5.4.3 South Africa Thalidomide Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Thalidomide Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Thalidomide Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Thalidomide Sales and Growth Rate (2012-2017)

6 EMEA THALIDOMIDE MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Celgene
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Thalidomide Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Celgene Thalidomide Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview

7 THALIDOMIDE MANUFACTURING COST ANALYSIS

7.1 Thalidomide Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Thalidomide

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Thalidomide Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Thalidomide Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA THALIDOMIDE MARKET FORECAST (2017-2022)

11.1 EMEA Thalidomide Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Thalidomide Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Thalidomide Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Thalidomide Price and Trend Forecast (2017-2022)
11.2 EMEA Thalidomide Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Thalidomide Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Thalidomide Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Thalidomide Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Thalidomide Sales Forecast by Type (2017-2022)
11.7 EMEA Thalidomide Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Thalidomide
Figure EMEA Thalidomide Sales Volume (K MT) by Type (2012-2022)
Figure EMEA Thalidomide Sales Volume Market Share by Type (Product Category) in 2016
Figure Purity:98% Product Picture
Figure Others Product Picture
Figure EMEA Thalidomide Sales Volume (K MT) by Application (2012-2022)
Figure EMEA Sales Market Share of Thalidomide by Application in 2016
Figure Leprosy Examples
Table Key Downstream Customer in Leprosy
Figure Arthropathy Examples
Table Key Downstream Customer in Arthropathy
Figure EMEA Thalidomide Market Size (Million USD) by Region (2012-2022)
Figure Europe Thalidomide Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Thalidomide Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Thalidomide Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Thalidomide Revenue (Million USD) Status and Forecast by Countries
Figure Africa Thalidomide Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Thalidomide Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Thalidomide Sales Volume and Growth Rate (2012-2022)
Figure EMEA Thalidomide Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Thalidomide Market Major Players Product Sales Volume (K MT) (2012-2017)
Table EMEA Thalidomide Sales Volume (K MT) of Major Players (2012-2017)
Table EMEA Thalidomide Sales Share by Players (2012-2017)
Figure 2016 Thalidomide Sales Share by Players
Figure 2017 Thalidomide Sales Share by Players
Figure EMEA Thalidomide Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Thalidomide Revenue (Million USD) by Players (2012-2017)
Table EMEA Thalidomide Revenue Share by Players (2012-2017)
Table 2016 EMEA Thalidomide Revenue Share by Players
Table 2017 EMEA Thalidomide Revenue Share by Players
Table EMEA Thalidomide Sale Price (USD/MT) by Players (2012-2017)
Table EMEA Thalidomide Sales (K MT) and Market Share by Type (2012-2017)
Table EMEA Thalidomide Sales Share by Type (2012-2017)
Figure Sales Market Share of Thalidomide by Type (2012-2017)
Figure EMEA Thalidomide Sales Market Share by Type (2012-2017)
Table EMEA Thalidomide Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Thalidomide Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Thalidomide by Type in 2016
Table EMEA Thalidomide Sale Price (USD/MT) by Type (2012-2017)
Table EMEA Thalidomide Sales (K MT) and Market Share by Application (2012-2017)
Table EMEA Thalidomide Sales Share by Application (2012-2017)
Figure Sales Market Share of Thalidomide by Application (2012-2017)
Figure EMEA Thalidomide Sales Market Share by Application in 2016
Table EMEA Thalidomide Sales (K MT) and Market Share by Region (2012-2017)
Table EMEA Thalidomide Sales Share by Region (2012-2017)
Figure Sales Market Share of Thalidomide by Region (2012-2017)
Figure EMEA Thalidomide Sales Market Share in 2016
Table EMEA Thalidomide Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Thalidomide Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Thalidomide by Region (2012-2017)
Figure EMEA Thalidomide Revenue Market Share Regions in 2016
Table EMEA Thalidomide Sales Price (USD/MT) by Region (2012-2017)
Figure Europe Thalidomide Sales (K MT) and Growth Rate (2012-2017)
Figure Europe Thalidomide Revenue and Growth Rate (2012-2017)
Table Europe Thalidomide Sales (K MT) by Type (2012-2017)
Table Europe Thalidomide Market Share by Type (2012-2017)
Figure Europe Thalidomide Market Share by Type in 2016
Table Europe Thalidomide Sales (K MT) by Application (2012-2017)
Table Europe Thalidomide Market Share by Application (2012-2017)
Figure Europe Thalidomide Market Share by Application in 2016
Table Europe Thalidomide Sales (K MT) by Countries (2012-2017)
Table Europe Thalidomide Sales Market Share by Countries (2012-2017)
Figure Europe Thalidomide Sales Market Share by Countries (2012-2017)
Figure Europe Thalidomide Sales Market Share by Countries in 2016
Table Europe Thalidomide Revenue (Million USD) by Countries (2012-2017)
Table Europe Thalidomide Revenue Market Share by Countries (2012-2017)
Figure Europe Thalidomide Revenue Market Share by Countries (2012-2017)
Figure Europe Thalidomide Revenue Market Share by Countries in 2016
Figure Germany Thalidomide Sales (K MT) and Growth Rate (2012-2017)
Figure France Thalidomide Sales (K MT) and Growth Rate (2012-2017)
Figure UK Thalidomide Sales (K MT) and Growth Rate (2012-2017)
Figure Russia Thalidomide Sales (K MT) and Growth Rate (2012-2017)
Figure Italy Thalidomide Sales (K MT) and Growth Rate (2012-2017)
Figure Benelux Thalidomide Sales (K MT) and Growth Rate (2012-2017)
Figure Middle East Thalidomide Sales (K MT) and Growth Rate (2012-2017)
Figure Middle East Thalidomide Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Thalidomide Sales (K MT) by Type (2012-2017)
Table Middle East Thalidomide Market Share by Type (2012-2017)
Figure Middle East Thalidomide Market Share by Type (2012-2017)
Table Middle East Thalidomide Sales (K MT) by Applications (2012-2017)
Table Middle East Thalidomide Market Share by Applications (2012-2017)
Figure Middle East Thalidomide Sales Market Share by Application in 2016
Table Middle East Thalidomide Sales Volume (K MT) by Countries (2012-2017)
Table Middle East Thalidomide Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Thalidomide Sales Volume Market Share by Countries in 2016
Table Middle East Thalidomide Revenue (Million USD) by Countries (2012-2017)
Table Middle East Thalidomide Revenue Market Share by Countries (2012-2017)
Figure Middle East Thalidomide Revenue Market Share by Countries (2012-2017)
Figure Middle East Thalidomide Revenue Market Share by Countries in 2016
Figure Saudi Arabia Thalidomide Sales (K MT) and Growth Rate (2012-2017)
Figure Israel Thalidomide Sales (K MT) and Growth Rate (2012-2017)
Figure UAE Thalidomide Sales (K MT) and Growth Rate (2012-2017)
Figure Iran Thalidomide Sales (K MT) and Growth Rate (2012-2017)
Figure Africa Thalidomide Sales (K MT) and Growth Rate (2012-2017)
Figure Africa Thalidomide Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Thalidomide Sales (K MT) by Type (2012-2017)
Table Africa Thalidomide Sales Market Share by Type (2012-2017)
Figure Africa Thalidomide Sales Market Share by Type (2012-2017)
Figure Africa Thalidomide Sales Market Share by Type in 2016
Table Africa Thalidomide Sales (K MT) by Application (2012-2017)
Table Africa Thalidomide Sales Market Share by Application (2012-2017)
Figure Africa Thalidomide Sales Market Share by Application (2012-2017)
Table Africa Thalidomide Sales Volume (K MT) by Countries (2012-2017)
Table Africa Thalidomide Sales Market Share by Countries (2012-2017)
Figure Africa Thalidomide Sales Market Share by Countries (2012-2017)
Figure Africa Thalidomide Sales Market Share by Countries in 2016
Table Africa Thalidomide Revenue (Million USD) by Countries (2012-2017)
Table Africa Thalidomide Revenue Market Share by Countries (2012-2017)
Figure Africa Thalidomide Revenue Market Share by Countries (2012-2017)
Figure Africa Thalidomide Revenue Market Share by Countries in 2016
Figure South Africa Thalidomide Sales (K MT) and Growth Rate (2012-2017)
Figure Nigeria Thalidomide Sales (K MT) and Growth Rate (2012-2017)
Figure Egypt Thalidomide Sales (K MT) and Growth Rate (2012-2017)
Figure Algeria Thalidomide Sales (K MT) and Growth Rate (2012-2017)
Table Celgene Thalidomide Basic Information List
Table Celgene Thalidomide Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Celgene Thalidomide Sales (K MT) and Growth Rate (2012-2017)
Figure Celgene Thalidomide Sales Market Share in EMEA (2012-2017)
Figure Celgene Thalidomide Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Thalidomide
Figure Manufacturing Process Analysis of Thalidomide
Figure Thalidomide Industrial Chain Analysis
Table Raw Materials Sources of Thalidomide Major Manufacturers in 2016
Table Major Buyers of Thalidomide
Table Distributors/Traders List
Figure EMEA Thalidomide Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure EMEA Thalidomide Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Thalidomide Price (USD/MT) and Trend Forecast (2017-2022)
Table EMEA Thalidomide Sales (K MT) Forecast by Region (2017-2022)
Figure EMEA Thalidomide Sales Market Share Forecast by Region (2017-2022)
Table EMEA Thalidomide Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Thalidomide Revenue Market Share Forecast by Region (2017-2022)
Table Europe Thalidomide Sales (K MT) Forecast by Countries (2017-2022)
Figure Europe Thalidomide Sales Market Share Forecast by Countries (2017-2022)
Table Europe Thalidomide Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Thalidomide Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Thalidomide Sales (K MT) Forecast by Countries (2017-2022)
Figure Middle East Thalidomide Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Thalidomide Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Thalidomide Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Thalidomide Sales (K MT) Forecast by Countries (2017-2022)
Figure Africa Thalidomide Sales Market Share Forecast by Countries (2017-2022)
Table Africa Thalidomide Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Thalidomide Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Thalidomide Sales (K MT) Forecast by Type (2017-2022)
Figure EMEA Thalidomide Sales Market Share Forecast by Type (2017-2022)
Table EMEA Thalidomide Sales (K MT) Forecast by Application (2017-2022)
Figure EMEA Thalidomide Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources